scispace - formally typeset
M

Maria Carla Roncaglioni

Researcher at Mario Negri Institute for Pharmacological Research

Publications -  106
Citations -  9313

Maria Carla Roncaglioni is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 25, co-authored 93 publications receiving 8377 citations. Previous affiliations of Maria Carla Roncaglioni include Maastricht University.

Papers
More filters
Journal ArticleDOI

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

TL;DR: In primary prevention without previous disease, aspirin is of uncertain net value as the reduction in occlusive events needs to be weighed against any increase in major bleeds.
Journal ArticleDOI

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice

TL;DR: In women and men at risk of having a cardiovascular event because of the presence of at least one major risk factor, low-dose aspirin given in addition to treatment of specific risk factors contributes an additional preventive effect, with an acceptable safety profile.
Journal ArticleDOI

Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-analysis of Randomized Controlled Trials

TL;DR: For women and men, aspirin therapy reduced the risk of a composite of cardiovascular events due to its effect on reducing therisk of ischemic stroke in women and MI in men.
Journal ArticleDOI

Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke

L Candelise, +320 more
- 09 Dec 1995 -